Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes
Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequ...
Gespeichert in:
Veröffentlicht in: | Journal of virology 2020-07, Vol.94 (16) |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 16 |
container_start_page | |
container_title | Journal of virology |
container_volume | 94 |
creator | Chemudupati, Mahesh Kenney, Adam D Smith, Anna C Fillinger, Robert J Zhang, Lizhi Zani, Ashley Liu, Shan-Lu Anderson, Matthew Z Sharma, Amit Yount, Jacob S |
description | Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.
Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines. |
doi_str_mv | 10.1128/JVI.00326-20 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7394905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32461320</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbK3ePEt-gKmzn8leBC1trQiCVfG2bDaTGmmTsJuK_fdGq0VPAzPv-ww8hJxSGFLK0ovb59kQgDMVM9gjfQo6jaWkYp_0ARiLJU9feuQohDcAKoQSh6THmVCUM-iTyfW63XjbYvSAja8X3q5CNP5oPIZQ1lVUF9G8QVcWpYtmVYu-QF9X8bwtV-tlV8ujKVYYjslBYZcBT37mgDxNxo-jm_jufjobXd3FTuikjR1S4UCxTKvMppoJVC61SZ7rNHUWpdVUpDSXwlHRLTUkMpM2B0CutFIJH5DLLbdZZyvMHVatt0vT-HJl_cbUtjT_L1X5ahb1u0m4FhpkBzjfApyvQ_BY7LoUzJdP0_k03z4Ngy5-9vffLvwrkH8C3LVyTQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Chemudupati, Mahesh ; Kenney, Adam D ; Smith, Anna C ; Fillinger, Robert J ; Zhang, Lizhi ; Zani, Ashley ; Liu, Shan-Lu ; Anderson, Matthew Z ; Sharma, Amit ; Yount, Jacob S</creator><creatorcontrib>Chemudupati, Mahesh ; Kenney, Adam D ; Smith, Anna C ; Fillinger, Robert J ; Zhang, Lizhi ; Zani, Ashley ; Liu, Shan-Lu ; Anderson, Matthew Z ; Sharma, Amit ; Yount, Jacob S</creatorcontrib><description>Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.
Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.00326-20</identifier><identifier>PMID: 32461320</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antiviral Agents - pharmacology ; Butyrates - metabolism ; Butyrates - pharmacology ; Cell Line ; Cellular Response to Infection ; Gene Expression - drug effects ; Gene Expression - genetics ; Humans ; Immunity, Innate - drug effects ; Interferon Type I - drug effects ; Interferon Type I - metabolism ; Interferons - metabolism ; Membrane Proteins - metabolism ; Mice ; RNA-Binding Proteins - metabolism ; Signal Transduction - drug effects ; STAT1 Transcription Factor - metabolism ; STAT2 Transcription Factor - metabolism ; Virus Diseases ; Virus Replication - drug effects</subject><ispartof>Journal of virology, 2020-07, Vol.94 (16)</ispartof><rights>Copyright © 2020 American Society for Microbiology.</rights><rights>Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</citedby><cites>FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</cites><orcidid>0000-0003-1683-2170</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394905/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394905/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32461320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chemudupati, Mahesh</creatorcontrib><creatorcontrib>Kenney, Adam D</creatorcontrib><creatorcontrib>Smith, Anna C</creatorcontrib><creatorcontrib>Fillinger, Robert J</creatorcontrib><creatorcontrib>Zhang, Lizhi</creatorcontrib><creatorcontrib>Zani, Ashley</creatorcontrib><creatorcontrib>Liu, Shan-Lu</creatorcontrib><creatorcontrib>Anderson, Matthew Z</creatorcontrib><creatorcontrib>Sharma, Amit</creatorcontrib><creatorcontrib>Yount, Jacob S</creatorcontrib><title>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.
Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.</description><subject>Animals</subject><subject>Antiviral Agents - pharmacology</subject><subject>Butyrates - metabolism</subject><subject>Butyrates - pharmacology</subject><subject>Cell Line</subject><subject>Cellular Response to Infection</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - genetics</subject><subject>Humans</subject><subject>Immunity, Innate - drug effects</subject><subject>Interferon Type I - drug effects</subject><subject>Interferon Type I - metabolism</subject><subject>Interferons - metabolism</subject><subject>Membrane Proteins - metabolism</subject><subject>Mice</subject><subject>RNA-Binding Proteins - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>STAT1 Transcription Factor - metabolism</subject><subject>STAT2 Transcription Factor - metabolism</subject><subject>Virus Diseases</subject><subject>Virus Replication - drug effects</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdRbK3ePEt-gKmzn8leBC1trQiCVfG2bDaTGmmTsJuK_fdGq0VPAzPv-ww8hJxSGFLK0ovb59kQgDMVM9gjfQo6jaWkYp_0ARiLJU9feuQohDcAKoQSh6THmVCUM-iTyfW63XjbYvSAja8X3q5CNP5oPIZQ1lVUF9G8QVcWpYtmVYu-QF9X8bwtV-tlV8ujKVYYjslBYZcBT37mgDxNxo-jm_jufjobXd3FTuikjR1S4UCxTKvMppoJVC61SZ7rNHUWpdVUpDSXwlHRLTUkMpM2B0CutFIJH5DLLbdZZyvMHVatt0vT-HJl_cbUtjT_L1X5ahb1u0m4FhpkBzjfApyvQ_BY7LoUzJdP0_k03z4Ngy5-9vffLvwrkH8C3LVyTQ</recordid><startdate>20200730</startdate><enddate>20200730</enddate><creator>Chemudupati, Mahesh</creator><creator>Kenney, Adam D</creator><creator>Smith, Anna C</creator><creator>Fillinger, Robert J</creator><creator>Zhang, Lizhi</creator><creator>Zani, Ashley</creator><creator>Liu, Shan-Lu</creator><creator>Anderson, Matthew Z</creator><creator>Sharma, Amit</creator><creator>Yount, Jacob S</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1683-2170</orcidid></search><sort><creationdate>20200730</creationdate><title>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</title><author>Chemudupati, Mahesh ; Kenney, Adam D ; Smith, Anna C ; Fillinger, Robert J ; Zhang, Lizhi ; Zani, Ashley ; Liu, Shan-Lu ; Anderson, Matthew Z ; Sharma, Amit ; Yount, Jacob S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Antiviral Agents - pharmacology</topic><topic>Butyrates - metabolism</topic><topic>Butyrates - pharmacology</topic><topic>Cell Line</topic><topic>Cellular Response to Infection</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - genetics</topic><topic>Humans</topic><topic>Immunity, Innate - drug effects</topic><topic>Interferon Type I - drug effects</topic><topic>Interferon Type I - metabolism</topic><topic>Interferons - metabolism</topic><topic>Membrane Proteins - metabolism</topic><topic>Mice</topic><topic>RNA-Binding Proteins - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>STAT1 Transcription Factor - metabolism</topic><topic>STAT2 Transcription Factor - metabolism</topic><topic>Virus Diseases</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chemudupati, Mahesh</creatorcontrib><creatorcontrib>Kenney, Adam D</creatorcontrib><creatorcontrib>Smith, Anna C</creatorcontrib><creatorcontrib>Fillinger, Robert J</creatorcontrib><creatorcontrib>Zhang, Lizhi</creatorcontrib><creatorcontrib>Zani, Ashley</creatorcontrib><creatorcontrib>Liu, Shan-Lu</creatorcontrib><creatorcontrib>Anderson, Matthew Z</creatorcontrib><creatorcontrib>Sharma, Amit</creatorcontrib><creatorcontrib>Yount, Jacob S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chemudupati, Mahesh</au><au>Kenney, Adam D</au><au>Smith, Anna C</au><au>Fillinger, Robert J</au><au>Zhang, Lizhi</au><au>Zani, Ashley</au><au>Liu, Shan-Lu</au><au>Anderson, Matthew Z</au><au>Sharma, Amit</au><au>Yount, Jacob S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2020-07-30</date><risdate>2020</risdate><volume>94</volume><issue>16</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.
Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>32461320</pmid><doi>10.1128/JVI.00326-20</doi><orcidid>https://orcid.org/0000-0003-1683-2170</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-538X |
ispartof | Journal of virology, 2020-07, Vol.94 (16) |
issn | 0022-538X 1098-5514 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7394905 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Animals Antiviral Agents - pharmacology Butyrates - metabolism Butyrates - pharmacology Cell Line Cellular Response to Infection Gene Expression - drug effects Gene Expression - genetics Humans Immunity, Innate - drug effects Interferon Type I - drug effects Interferon Type I - metabolism Interferons - metabolism Membrane Proteins - metabolism Mice RNA-Binding Proteins - metabolism Signal Transduction - drug effects STAT1 Transcription Factor - metabolism STAT2 Transcription Factor - metabolism Virus Diseases Virus Replication - drug effects |
title | Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A34%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Butyrate%20Reprograms%20Expression%20of%20Specific%20Interferon-Stimulated%20Genes&rft.jtitle=Journal%20of%20virology&rft.au=Chemudupati,%20Mahesh&rft.date=2020-07-30&rft.volume=94&rft.issue=16&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.00326-20&rft_dat=%3Cpubmed_cross%3E32461320%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32461320&rfr_iscdi=true |